Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)
Clinical trial NCT00163540 · COMPLETED
Trial details
- NCT number
- NCT00163540
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.